speb/financial-data huggingface dataset:
DEA income_statement (annual, 2025-12-31) — +Operating Expense: 139493000.00
DEA income_statement (quarterly, 2025-12-31) — +Operating Expense: 36861000.00
DEA income_statement (annual, 2025-12-31) — +Total Revenue: 336099000.00
DEA income_statement (quarterly, 2025-12-31) — +Total Revenue: 87039000.00
DEA balance_sheet (annual, 2025-12-31) — Accounts Payable: 109686000.00
DEA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 109686000.00
DEA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 51493000.00
DEA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 51493000.00
DEA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1958412000.00
DEA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1958412000.00
DEA cash_flow (annual, 2025-12-31) — Amortization Cash Flow: -1829000.00
DEA cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: -402000.00
DEA cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: -1829000.00
DEA cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: -402000.00
DEA cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 2545000.00
DEA cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
DEA income_statement (annual, 2025-12-31) — Basic Average Shares: 44922497.00
DEA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 46081121.00
DEA income_statement (annual, 2025-12-31) — Basic EPS: 0.27
DEA income_statement (quarterly, 2025-12-31) — Basic EPS: 0.10
DEA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 27804000.00
DEA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14209000.00
DEA balance_sheet (annual, 2025-12-31) — Capital Stock: 463000.00
DEA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 463000.00
DEA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 23374000.00
DEA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 23374000.00
DEA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 23374000.00
DEA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 23374000.00
DEA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -94590000.00
DEA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -21708000.00
DEA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 31918000.00
DEA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5217000.00
DEA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -285285000.00
DEA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -27726000.00
DEA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 259194000.00
DEA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 41931000.00
DEA cash_flow (annual, 2025-12-31) — Change In Account Payable: 4306000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -5566000.00
DEA cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 105962000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 893000.00
DEA cash_flow (annual, 2025-12-31) — Change In Payable: 4306000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Payable: -5566000.00
DEA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4306000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -5566000.00
DEA cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -12411000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -4183000.00
DEA cash_flow (annual, 2025-12-31) — Change In Receivables: 18269000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 13504000.00
DEA cash_flow (annual, 2025-12-31) — Change In Working Capital: 116126000.00
DEA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4648000.00
DEA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 21025000.00
DEA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 14335000.00
DEA cash_flow (annual, 2025-12-31) — Changes In Cash: 5827000.00
DEA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 19422000.00
DEA balance_sheet (annual, 2025-12-31) — Common Stock: 463000.00
DEA balance_sheet (quarterly, 2025-12-31) — Common Stock: 463000.00
DEA cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -94590000.00
DEA cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -21708000.00
DEA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1323132000.00
DEA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1323132000.00
DEA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 63620000.00
DEA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
DEA income_statement (annual, 2025-12-31) — Cost Of Revenue: 111411000.00
DEA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 28430000.00
DEA balance_sheet (annual, 2025-12-31) — Current Assets: 119410000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Assets: 119410000.00
DEA balance_sheet (annual, 2025-12-31) — Current Debt: 199050000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Debt: 199050000.00
DEA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 199050000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 199050000.00
DEA balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 219201000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 219201000.00
DEA balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 219201000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 219201000.00
DEA balance_sheet (annual, 2025-12-31) — Current Liabilities: 527937000.00
DEA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 527937000.00
DEA cash_flow (annual, 2025-12-31) — Depreciation: 113897000.00
DEA cash_flow (quarterly, 2025-12-31) — Depreciation: 29620000.00
DEA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 112068000.00
DEA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 29218000.00
DEA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 113897000.00
DEA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 29620000.00
DEA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 112068000.00
DEA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 29218000.00
DEA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 113897000.00
DEA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 29620000.00
DEA balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 3034000.00
DEA balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 3034000.00
DEA income_statement (annual, 2025-12-31) — Diluted Average Shares: 45057895.00
DEA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 46267150.00
DEA income_statement (annual, 2025-12-31) — Diluted EPS: 0.27
DEA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.10
DEA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 12320000.00
DEA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 4404000.00
DEA cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 18580000.00
DEA cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 3367000.00
DEA cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 0.00
DEA cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 0.00
DEA income_statement (annual, 2025-12-31) — EBIT: 88011000.00
DEA income_statement (quarterly, 2025-12-31) — EBIT: 22853000.00
DEA income_statement (annual, 2025-12-31) — EBITDA: 201908000.00
DEA income_statement (quarterly, 2025-12-31) — EBITDA: 52473000.00
DEA income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 6781000.00
DEA income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 1563000.00
DEA cash_flow (annual, 2025-12-31) — End Cash Position: 33631000.00
DEA cash_flow (quarterly, 2025-12-31) — End Cash Position: 33631000.00
DEA balance_sheet (annual, 2025-12-31) — Financial Assets: 0.00
DEA balance_sheet (quarterly, 2025-12-31) — Financial Assets: 0.00
DEA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 31918000.00
DEA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5217000.00
DEA cash_flow (annual, 2025-12-31) — Free Cash Flow: 259194000.00
DEA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 41931000.00
DEA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -780600000.00
DEA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -780600000.00
DEA income_statement (annual, 2025-12-31) — General And Administrative Expense: 26041000.00
DEA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7211000.00
DEA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 183911000.00
DEA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 183911000.00
DEA income_statement (annual, 2025-12-31) — Gross Profit: 224688000.00
DEA income_statement (quarterly, 2025-12-31) — Gross Profit: 58609000.00
DEA income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 2545000.00
DEA income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
DEA income_statement (annual, 2025-12-31) — Interest Expense: 74454000.00
DEA income_statement (quarterly, 2025-12-31) — Interest Expense: 18080000.00
DEA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 74454000.00
DEA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18080000.00
DEA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 79106000.00
DEA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 27434000.00
DEA balance_sheet (annual, 2025-12-31) — Invested Capital: 2989457000.00
DEA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2989457000.00
DEA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -285285000.00
DEA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -27726000.00
DEA balance_sheet (annual, 2025-12-31) — Investment Properties: 2714650000.00
DEA balance_sheet (quarterly, 2025-12-31) — Investment Properties: 2714650000.00
DEA balance_sheet (annual, 2025-12-31) — Investments And Advances: 304721000.00
DEA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 304721000.00
DEA balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 304721000.00
DEA balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 304721000.00
DEA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 63620000.00
DEA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
DEA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 493000000.00
DEA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 68150000.00
DEA balance_sheet (annual, 2025-12-31) — Line Of Credit: 199050000.00
DEA balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 199050000.00
DEA balance_sheet (annual, 2025-12-31) — Loans Receivable: 34286000.00
DEA balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 34286000.00
DEA balance_sheet (annual, 2025-12-31) — Long Term Debt: 1467275000.00
DEA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1467275000.00
DEA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1467275000.00
DEA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1467275000.00
DEA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 493000000.00
DEA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 68150000.00
DEA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -422598000.00
DEA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -41177000.00
DEA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 304721000.00
DEA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 304721000.00
DEA balance_sheet (annual, 2025-12-31) — Minority Interest: 46433000.00
DEA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 46433000.00
DEA income_statement (annual, 2025-12-31) — Minority Interests: -554000.00
DEA income_statement (quarterly, 2025-12-31) — Minority Interests: -181000.00
DEA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
DEA cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
DEA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 63620000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
DEA balance_sheet (annual, 2025-12-31) — Net Debt: 1642951000.00
DEA balance_sheet (quarterly, 2025-12-31) — Net Debt: 1642951000.00
DEA income_statement (annual, 2025-12-31) — Net Income: 13003000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income: 4592000.00
DEA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 12320000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 4404000.00
DEA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 13557000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 4773000.00
DEA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 13003000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4592000.00
DEA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 13003000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4592000.00
DEA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 13557000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 4773000.00
DEA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 13557000.00
DEA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 4773000.00
DEA income_statement (annual, 2025-12-31) — Net Interest Income: -74454000.00
DEA income_statement (quarterly, 2025-12-31) — Net Interest Income: -18080000.00
DEA cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: -287246000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: -28234000.00
DEA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 70402000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 26973000.00
DEA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 70402000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 26973000.00
DEA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -74454000.00
DEA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -18080000.00
DEA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -7514000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -48000.00
DEA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 1961000.00
DEA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 508000.00
DEA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1139221000.00
DEA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1139221000.00
DEA income_statement (annual, 2025-12-31) — Normalized EBITDA: 205873000.00
DEA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 52931000.00
DEA income_statement (annual, 2025-12-31) — Normalized Income: 16135350.00
DEA income_statement (quarterly, 2025-12-31) — Normalized Income: 4953820.00
DEA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 259194000.00
DEA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 41931000.00
DEA income_statement (annual, 2025-12-31) — Operating Income: 85195000.00
DEA income_statement (quarterly, 2025-12-31) — Operating Income: 21748000.00
DEA income_statement (annual, 2025-12-31) — Operating Revenue: 324213000.00
DEA income_statement (quarterly, 2025-12-31) — Operating Revenue: 84223000.00
DEA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 46303469.00
DEA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 46303469.00
DEA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -780600000.00
DEA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -780600000.00
DEA income_statement (annual, 2025-12-31) — Other Gand A: 26041000.00
DEA income_statement (quarterly, 2025-12-31) — Other Gand A: 7211000.00
DEA income_statement (annual, 2025-12-31) — Other Income Expense: 2816000.00
DEA income_statement (quarterly, 2025-12-31) — Other Income Expense: 1105000.00
DEA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 183911000.00
DEA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 183911000.00
DEA cash_flow (annual, 2025-12-31) — Other Non Cash Items: -9282000.00
DEA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1701000.00
DEA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 57078000.00
DEA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 57078000.00
DEA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 11959000.00
DEA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 11959000.00
DEA income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 683000.00
DEA income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 188000.00
DEA balance_sheet (annual, 2025-12-31) — Payables: 109686000.00
DEA balance_sheet (quarterly, 2025-12-31) — Payables: 109686000.00
DEA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 109686000.00
DEA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 109686000.00
DEA income_statement (annual, 2025-12-31) — Pretax Income: 13557000.00
DEA income_statement (quarterly, 2025-12-31) — Pretax Income: 4773000.00
DEA income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: -445000.00
DEA income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 30000.00
DEA cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -445000.00
DEA cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 30000.00
DEA cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
DEA cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
DEA cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -290738000.00
DEA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -28234000.00
DEA balance_sheet (annual, 2025-12-31) — Receivables: 85779000.00
DEA balance_sheet (quarterly, 2025-12-31) — Receivables: 85779000.00
DEA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 113240000.00
DEA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 28832000.00
DEA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 112068000.00
DEA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 29218000.00
DEA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -422598000.00
DEA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -41177000.00
DEA balance_sheet (annual, 2025-12-31) — Restricted Cash: 10257000.00
DEA balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 10257000.00
DEA income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1420000.00
DEA income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 458000.00
DEA balance_sheet (annual, 2025-12-31) — Retained Earnings: 144857000.00
DEA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 144857000.00
DEA cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 3492000.00
DEA cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 0.00
DEA income_statement (annual, 2025-12-31) — Selling General And Administration: 26041000.00
DEA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7211000.00
DEA balance_sheet (annual, 2025-12-31) — Share Issued: 46303469.00
DEA balance_sheet (quarterly, 2025-12-31) — Share Issued: 46303469.00
DEA income_statement (annual, 2025-12-31) — Special Income Charges: -3965000.00
DEA income_statement (quarterly, 2025-12-31) — Special Income Charges: -458000.00
DEA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 6045000.00
DEA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1596000.00
DEA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1323132000.00
DEA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1323132000.00
DEA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1139221000.00
DEA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1139221000.00
DEA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -832650.00
DEA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -96180.00
DEA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
DEA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
DEA balance_sheet (annual, 2025-12-31) — Total Assets: 3379770000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Assets: 3379770000.00
DEA balance_sheet (annual, 2025-12-31) — Total Capitalization: 2790407000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2790407000.00
DEA balance_sheet (annual, 2025-12-31) — Total Debt: 1666325000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Debt: 1666325000.00
DEA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1369565000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1369565000.00
DEA income_statement (annual, 2025-12-31) — Total Expenses: 250904000.00
DEA income_statement (quarterly, 2025-12-31) — Total Expenses: 65291000.00
DEA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2010205000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2010205000.00
DEA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3260360000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3260360000.00
DEA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1482268000.00
DEA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1482268000.00
DEA income_statement (annual, 2025-12-31) — Total Unusual Items: -3965000.00
DEA income_statement (quarterly, 2025-12-31) — Total Unusual Items: -458000.00
DEA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3965000.00
DEA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -458000.00
DEA balance_sheet (annual, 2025-12-31) — Working Capital: -408527000.00
DEA balance_sheet (quarterly, 2025-12-31) — Working Capital: -408527000.00
DEA income_statement (quarterly, 2026-03-31) — +Operating Expense: 41912000.00
DEA income_statement (quarterly, 2026-03-31) — +Total Revenue: 91545000.00
DEA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 73041000.00
DEA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1961587000.00
DEA cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: -435000.00
DEA cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: -435000.00
DEA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 46260517.00
DEA income_statement (quarterly, 2026-03-31) — Basic EPS: 0.02
DEA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 33631000.00
DEA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 464000.00
DEA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2017000.00
DEA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2017000.00
DEA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -21810000.00
DEA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 25145000.00
DEA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -73433000.00
DEA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 27335000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1101000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 14535000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Payable: 1101000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 1101000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1652000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -19335000.00
DEA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5351000.00
DEA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -19272000.00
DEA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -20953000.00
DEA balance_sheet (quarterly, 2026-03-31) — Common Stock: 464000.00
DEA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -21810000.00
DEA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1308839000.00
DEA cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 2167000.00
DEA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 29068000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Assets: 130181000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Debt: 245050000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 245050000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 230031000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 230031000.00
DEA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 583284000.00
DEA cash_flow (quarterly, 2026-03-31) — Depreciation: 33221000.00
DEA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 32786000.00
DEA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 33221000.00
DEA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 32786000.00
DEA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 33221000.00
DEA balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 1010000.00
DEA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 46453599.00
DEA income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.02
DEA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1125000.00
DEA cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 2315000.00
DEA income_statement (quarterly, 2026-03-31) — EBIT: 21580000.00
DEA income_statement (quarterly, 2026-03-31) — EBITDA: 54801000.00
DEA income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 1664000.00
DEA cash_flow (quarterly, 2026-03-31) — End Cash Position: 12678000.00
DEA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 25145000.00
DEA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 27335000.00
DEA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -799434000.00
DEA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 8495000.00
DEA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 189534000.00
DEA income_statement (quarterly, 2026-03-31) — Gross Profit: 62477000.00
DEA income_statement (quarterly, 2026-03-31) — Interest Expense: 20166000.00
DEA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 20166000.00
DEA cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 18522000.00
DEA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3020554000.00
DEA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -73433000.00
DEA balance_sheet (quarterly, 2026-03-31) — Investment Properties: 2738755000.00
DEA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 304070000.00
DEA balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 304070000.00
DEA cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2167000.00
DEA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 99250000.00
DEA balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 245050000.00
DEA balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 44462000.00
DEA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1466665000.00
DEA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1466665000.00
DEA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 99250000.00
DEA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -54440000.00
DEA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 304070000.00
DEA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 46664000.00
DEA income_statement (quarterly, 2026-03-31) — Minority Interests: -49000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2167000.00
DEA balance_sheet (quarterly, 2026-03-31) — Net Debt: 1709698000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income: 1365000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1125000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1414000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1365000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1365000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1414000.00
DEA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1414000.00
DEA income_statement (quarterly, 2026-03-31) — Net Interest Income: -20166000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -66503000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 44810000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 44810000.00
DEA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -20166000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -22000.00
DEA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -6930000.00
DEA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1119305000.00
DEA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 55450000.00
DEA income_statement (quarterly, 2026-03-31) — Normalized Income: 1754400.00
DEA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 27335000.00
DEA income_statement (quarterly, 2026-03-31) — Operating Income: 20565000.00
DEA income_statement (quarterly, 2026-03-31) — Operating Revenue: 89239000.00
DEA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 46444374.00
DEA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -799434000.00
DEA income_statement (quarterly, 2026-03-31) — Other Gand A: 8495000.00
DEA income_statement (quarterly, 2026-03-31) — Other Income Expense: 1015000.00
DEA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 189534000.00
DEA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -6122000.00
DEA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 57520000.00
DEA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 13598000.00
DEA income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 240000.00
DEA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 108203000.00
DEA income_statement (quarterly, 2026-03-31) — Pretax Income: 1414000.00
DEA income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 196000.00
DEA cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 196000.00
DEA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -66503000.00
DEA balance_sheet (quarterly, 2026-03-31) — Receivables: 117503000.00
DEA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 29503000.00
DEA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 32786000.00
DEA income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 20536000.00
DEA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -54440000.00
DEA balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 10661000.00
DEA income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 649000.00
DEA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 146222000.00
DEA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 8495000.00
DEA balance_sheet (quarterly, 2026-03-31) — Share Issued: 46444374.00
DEA income_statement (quarterly, 2026-03-31) — Special Income Charges: -649000.00
DEA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2097000.00
DEA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1308839000.00
DEA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1119305000.00
DEA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -259600.00
DEA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
DEA balance_sheet (quarterly, 2026-03-31) — Total Assets: 3420060000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2775504000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Debt: 1711715000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1355503000.00
DEA income_statement (quarterly, 2026-03-31) — Total Expenses: 70980000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2064557000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3289879000.00
DEA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1481273000.00
DEA income_statement (quarterly, 2026-03-31) — Total Unusual Items: -649000.00
DEA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -649000.00
DEA balance_sheet (quarterly, 2026-03-31) — Working Capital: -453103000.00
DEAL.V cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 2455652.00
DEAL.V cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 2455652.00
DEAL.V cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
DEAL.V balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 714078.00
DEAL.V cash_flow (annual, 2021-12-31) — Capital Expenditure: -480563.00
DEAL.V balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 579430.00
DEAL.V cash_flow (annual, 2021-12-31) — Cash Dividends Paid: 0.00
DEAL.V cash_flow (annual, 2021-12-31) — Change In Other Current Assets: 0.00
DEAL.V cash_flow (annual, 2021-12-31) — Common Stock Issuance: 10491334.00
DEAL.V balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 389084.00
DEAL.V cash_flow (annual, 2021-12-31) — Depreciation: 661577.00
DEAL.V income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
DEAL.V balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 8497522.00
DEAL.V cash_flow (annual, 2021-12-31) — Interest Paid Cff: -22345.00
DEAL.V cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 10491334.00
DEAL.V balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 190346.00
DEAL.V balance_sheet (annual, 2021-12-31) — Long Term Debt: 60000.00
DEAL.V balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 250346.00
DEAL.V cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 20000.00
DEAL.V cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 10491334.00
DEAL.V cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 11006.00
DEAL.V cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
DEAL.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -222151.00
DEAL.V balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 0.00
DEAL.V balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 8497522.00
DEAL.V balance_sheet (annual, 2021-12-31) — Other Payable: 42881.00
DEAL.V income_statement (annual, 2021-12-31) — Other Special Charges: -191031.00
DEAL.V cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 8112019.00
DEAL.V cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
DEAL.V balance_sheet (annual, 2021-12-31) — Restricted Cash: 440145.00
DEAL.V income_statement (annual, 2021-12-31) — Write Off: 0.00
DEAL.V income_statement (annual, 2022-12-31) — +Operating Expense: 9113772.00
DEAL.V income_statement (annual, 2022-12-31) — +Total Revenue: 957745.00
DEAL.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 3016399.00
DEAL.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 260115.00
DEAL.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1437903.00
DEAL.V cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2455652.00
DEAL.V cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 2455652.00
DEAL.V income_statement (annual, 2022-12-31) — Basic Average Shares: 253331449.00
DEAL.V income_statement (annual, 2022-12-31) — Basic EPS: -0.07
DEAL.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 5930003.00
DEAL.V balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 459875.00
DEAL.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -29631.00
DEAL.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 203348.00
DEAL.V balance_sheet (annual, 2022-12-31) — Capital Stock: 54533474.00
DEAL.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 206781.00
DEAL.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 206781.00
DEAL.V cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
DEAL.V balance_sheet (annual, 2022-12-31) — Cash Financial: 206781.00
DEAL.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5518922.00
DEAL.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -29631.00
DEAL.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -11187931.00
DEAL.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1569100.00
DEAL.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 82911.00
DEAL.V cash_flow (annual, 2022-12-31) — Change In Receivables: -180631.00
DEAL.V cash_flow (annual, 2022-12-31) — Change In Working Capital: 1471380.00
DEAL.V cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -97635.00
DEAL.V cash_flow (annual, 2022-12-31) — Changes In Cash: -5698640.00
DEAL.V balance_sheet (annual, 2022-12-31) — Common Stock: 54533474.00
DEAL.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: -2421189.00
DEAL.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
DEAL.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 8274272.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 528442.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Assets: 882057.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 203348.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Debt: 5807202.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 6010550.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 9714554.00
DEAL.V balance_sheet (annual, 2022-12-31) — Current Notes Payable: 5223000.00
DEAL.V cash_flow (annual, 2022-12-31) — Deferred Income Tax: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Deferred Tax: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Depreciation: 884077.00
DEAL.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3339729.00
DEAL.V income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 3339729.00
DEAL.V cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3339729.00
DEAL.V income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 3339729.00
DEAL.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 253331449.00
DEAL.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.07
DEAL.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — EBIT: -16568652.00
DEAL.V income_statement (annual, 2022-12-31) — EBITDA: -13228923.00
DEAL.V cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -24582.00
DEAL.V cash_flow (annual, 2022-12-31) — End Cash Position: 206781.00
DEAL.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 5518922.00
DEAL.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -11217562.00
DEAL.V income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -153984.00
DEAL.V balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 4734540.00
DEAL.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 4327655.00
DEAL.V balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6041870.00
DEAL.V balance_sheet (annual, 2022-12-31) — Gross PPE: 2286887.00
DEAL.V income_statement (annual, 2022-12-31) — Gross Profit: -7316527.00
DEAL.V cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
DEAL.V income_statement (annual, 2022-12-31) — Interest Expense: 254695.00
DEAL.V income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 254695.00
DEAL.V income_statement (annual, 2022-12-31) — Interest Income: 15631.00
DEAL.V income_statement (annual, 2022-12-31) — Interest Income Non Operating: 15631.00
DEAL.V cash_flow (annual, 2022-12-31) — Interest Paid Cff: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 29554.00
DEAL.V balance_sheet (annual, 2022-12-31) — Interest Payable: 279367.00
DEAL.V balance_sheet (annual, 2022-12-31) — Invested Capital: 4306013.00
DEAL.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -29631.00
DEAL.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5023000.00
DEAL.V balance_sheet (annual, 2022-12-31) — Leases: 987566.00
DEAL.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
DEAL.V balance_sheet (annual, 2022-12-31) — Long Term Debt: 920000.00
DEAL.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 920000.00
DEAL.V cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -424078.00
DEAL.V balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 485217.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
DEAL.V balance_sheet (annual, 2022-12-31) — Net Debt: 6520421.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -6187.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -16823347.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -16823347.00
DEAL.V income_statement (annual, 2022-12-31) — Net Interest Income: -239064.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4598922.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -424078.00
DEAL.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -239064.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 920000.00
DEAL.V balance_sheet (annual, 2022-12-31) — Net PPE: 848984.00
DEAL.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -29631.00
DEAL.V cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 5023000.00
DEAL.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -8463059.00
DEAL.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -13074939.00
DEAL.V income_statement (annual, 2022-12-31) — Normalized Income: -16669363.00
DEAL.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -11187931.00
DEAL.V cash_flow (annual, 2022-12-31) — Operating Gains Losses: -6187.00
DEAL.V income_statement (annual, 2022-12-31) — Operating Income: -16430299.00
DEAL.V income_statement (annual, 2022-12-31) — Operating Revenue: 957745.00
DEAL.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 253331449.00
DEAL.V balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 584202.00
DEAL.V income_statement (annual, 2022-12-31) — Other Gand A: 2813580.00
DEAL.V income_statement (annual, 2022-12-31) — Other Income Expense: -153984.00
DEAL.V balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 6041870.00
DEAL.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 216044.00
DEAL.V balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 440454.00
DEAL.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 1058073.00
DEAL.V balance_sheet (annual, 2022-12-31) — Other Payable: 34718.00
DEAL.V balance_sheet (annual, 2022-12-31) — Other Properties: 354229.00
DEAL.V balance_sheet (annual, 2022-12-31) — Payables: 3175562.00
DEAL.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3704004.00
DEAL.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 250800.00
DEAL.V income_statement (annual, 2022-12-31) — Pretax Income: -16823347.00
DEAL.V cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -29631.00
DEAL.V balance_sheet (annual, 2022-12-31) — Receivables: 424476.00
DEAL.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 8274272.00
DEAL.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3339729.00
DEAL.V income_statement (annual, 2022-12-31) — Rent And Landing Fees: 115307.00
DEAL.V income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 115307.00
DEAL.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -424078.00
DEAL.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -61689203.00
DEAL.V income_statement (annual, 2022-12-31) — Salaries And Wages: 1398768.00
DEAL.V income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 388315.00
DEAL.V income_statement (annual, 2022-12-31) — Selling General And Administration: 4715970.00
DEAL.V balance_sheet (annual, 2022-12-31) — Share Issued: 253331449.00
DEAL.V cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 5023000.00
DEAL.V cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
DEAL.V income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
DEAL.V cash_flow (annual, 2022-12-31) — Stock Based Compensation: 614450.00
DEAL.V balance_sheet (annual, 2022-12-31) — Stockholders Equity: -2421189.00
DEAL.V balance_sheet (annual, 2022-12-31) — Tangible Book Value: -8463059.00
DEAL.V income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
DEAL.V income_statement (annual, 2022-12-31) — Tax Provision: 0.00
DEAL.V income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
DEAL.V balance_sheet (annual, 2022-12-31) — Taxes Receivable: 164361.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Assets: 8213365.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Capitalization: -1501189.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Debt: 6930550.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -2421189.00
DEAL.V income_statement (annual, 2022-12-31) — Total Expenses: 17388044.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10634554.00
DEAL.V balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 7331308.00